Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
PulseAI wins FDA clearance for smartwatch ECG analysis after study shows 92% fewer inconclusive results
Read More Auto and Transport Industry News WeRide Inc. stock soars 21% amid robotaxi expansion and cloud alliance: A deep dive for investors WeRide Inc. stock soared 21% on May 21, 2025. Explore what’s driving the rally—robotaxis, cloud expansion, Uber partnerships, and a $100M buyback plan. byPallavi MadhirajuMay 22, 2025